SocraTec R&D Concepts in Drug Research & Development GmbH (SocraTec R&D Concepts in Drug Research & Development GmbH)

概览

关联

21

项与 SocraTec R&D Concepts in Drug Research & Development GmbH 相关的临床试验

NCT07307794

/ Recruiting临床1期

Characterisation of Adhesion Performance of a Newly Developed Esflurbiprofen Topical System (EFTS) - a Phase I, Open-label Study in Healthy Subjects.

This study is a single-center, open-label, multiple-dose trial in healthy participants. The primary purpose of this study is to assess the adhesion of TK-254RX. Secondary purposes are to assess the safety of TK-254RX and the residual amount of the patch.

开始日期2026-01-19

申办/合作机构

Teikoku Seiyaku Co. Ltd.

[+4]

CTIS2024-514302-31-00

/ Active, not recruiting临床2期

Investigation of 3 different doses of a newly developed vaginal ring releasing estriol for the treatment of vaginal atrophy - a placebo-controlled, double-blind, combined dose-finding and proof-of-concept trial with parallel-group design in postmenopausal women

开始日期2025-07-16

申办/合作机构

SocraTec R&D Concepts in Drug Research & Development GmbH

CTIS2025-521236-12-00

/ Active, not recruiting临床2期

A mono-centre, non-comparative clinical trial on the inhibition of ovulation with LNG POP (Levonorgestrel tablet, 0.135 mg) during three 28-day cycles with continuous treatment and intentional intake errors

开始日期2025-07-02

申办/合作机构

SocraTec R&D Concepts in Drug Research & Development GmbH

100 项与 SocraTec R&D Concepts in Drug Research & Development GmbH 相关的临床结果

登录后查看更多信息

0 项与 SocraTec R&D Concepts in Drug Research & Development GmbH 相关的专利（医药）

登录后查看更多信息

100 项与 SocraTec R&D Concepts in Drug Research & Development GmbH 相关的药物交易

登录后查看更多信息

100 项与 SocraTec R&D Concepts in Drug Research & Development GmbH 相关的转化医学

登录后查看更多信息